Untitled Document
Taking a Closer Look at the Stories Ignored by the Corporate Media
Donate | Fair Use Notice | Who We Are | Contact

NEWS
All News
9-11
Corporatism
Disaster in New Orleans
Economics
Environment
Globalization
Government / The Elite
Human Rights
International Affairs
Iraq War
London Bombing
Media
Police State / Military
Science / Health
Voting Integrity
War on Terrorism
Miscellaneous

COMMENTARY
All Commentaries
9-11
CIA
Corporatism
Economics
Government / The Elite
Imperialism
Iraq War
Media
Police State / Military
Science / Health
Voting Integrity
War on Terrorism

SEARCH/ARCHIVES
Advanced Search
View the Archives

E-mail this Link   Printer Friendly

CORPORATISM -
-

Med School Profs Attack Consumer Drug Marketing

Posted in the database on Monday, October 31st, 2005 @ 19:24:26 MST (1496 views)
by Brendan Coyne    The New Standard  

Untitled Document

A week away from federal hearings on drug-marketing practices, more than 200 prominent medical academics signed on to a call for an end to pharmaceutical industry advertising practices aimed directly at consumers. The action comes amid growing concern among medical practitioners that direct-to-consumer marketing of drug and medical services is undermining the integrity in health care.

According to the statement, which was signed by professors at many of the nation's most prestigious medical schools and former New England Journal of Medicine editors, the drug industry spent over $4 billion advertising drugs last year. In addition, pharmaceutical companies spend between $900 million and $1 billion a year on medical education classes and showering medical school students with gifts.

Facing public and political pressure, the Pharmaceutical Research and Manufacturers Association (PhRMA), the nation's largest drug company lobby, in August announced voluntary marketing rules for member companies to adopt. The rules included suggestions that firms submit television advertisements to the Food and Drug Administration before release, that commercials state the health condition for which the medicine being advertised is approved, and that advertisements "balance" presentation of the risks and benefits of the marketed medication.

But the 211 medical professionals who signed the statement are calling for a moratorium on direct-to-consumer advertising or, at least, FDA regulation of the practice. They warn that pharmaceutical companies cannot be trusted to regulate their own marketing activities because they have an "inherent and irredeemable financial conflict of interest, which drives them to exaggerate the positive and minimize the negative qualities of their own products."

Commercial Alert, a consumer advocacy group, will present the statement at next week's FDA hearings. The group crafted the statement and recruited medical school professors from Yale, Harvard, Johns Hopkins, Columbia and dozens of other schools to sign on.



Go to Original Article >>>

The views expressed herein are the writers' own and do not necessarily reflect those of Looking Glass News. Click the disclaimer link below for more information.
Email: editor@lookingglassnews.org.

E-mail this Link   Printer Friendly




Untitled Document
Disclaimer
Donate | Fair Use Notice | Who We Are | Contact
Copyright 2005 Looking Glass News.